FOXP3 and cerebral malaria: Mesenchymal stem cells alleviate experimental cerebral malaria disease severity by inducing RoRγt&lt;sup&gt;+&lt;/sup&gt; Foxp3&lt;sup&gt;+&lt;/sup&gt; T regulatory (Tr 17) cells and modulating the dysregulated Th17/Treg axis.